Quinoline-derived amide modulators of vanilloid VR1 receptor
US8394828B2 · kind B2 · utility
0Cited by
4References
142Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 16, 2008 |
| Grant date | Mar 12, 2013 |
| Priority date | — |
| Expiry date | Jun 13, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to quinoline-derived amides that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.